# Cardinal Health, Inc. (CAH) FY2026 Q3 Balance Sheet

- Company: Cardinal Health, Inc. (CAH)
- Period: As of 2026-03-31
- Filing: Q3 FY2026 10-Q, filed 2026-04-30, accession number 0000721371-26-000018
- Page: https://plicit.ai/financials/cah/fy2026-q3-balance-sheet
- Chart image: https://plicit.ai/charts/cah-fy2026-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 56,689,000,000 US dollars
- **Current assets**: 38,064,000,000 US dollars
- **Non-current assets**: 18,625,000,000 US dollars
- **Liabilities (calculated)**: 59,361,000,000 US dollars
- **Current liabilities**: 41,989,000,000 US dollars
- **Non-current liabilities**: 17,372,000,000 US dollars
- **Equity**: negative 2,672,000,000 US dollars
- **Noncontrolling interest**: 160,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Inventories, net**: 18,007,000,000 US dollars
- **Trade receivables, net**: 13,648,000,000 US dollars
- **Cash and equivalents**: 3,937,000,000 US dollars
- **Prepaid expenses and other**: 2,472,000,000 US dollars
- **Assets held for sale**: 0 US dollars
- **Goodwill and other intangibles, net**: 13,698,000,000 US dollars
- **Property and equipment, net**: 2,928,000,000 US dollars
- **Other assets**: 1,999,000,000 US dollars
- **Accounts payable**: 37,834,000,000 US dollars
- **Other accrued liabilities**: 3,484,000,000 US dollars
- **Current portion of long-term obligations and other short-term borrowings**: 671,000,000 US dollars
- **Deferred income taxes and other liabilities**: 9,127,000,000 US dollars
- **Long-term obligations, less current portion**: 8,245,000,000 US dollars
- **Authorized—755 million shares, Issued—271 million shares at March 31, 2026 and June 30, 2025**: 2,815,000,000 US dollars
- **Retained earnings**: 1,732,000,000 US dollars
- **Authorized—500 thousand shares, Issued—none**: 0 US dollars
- **Noncontrolling interests**: 160,000,000 US dollars
- **Common shares in treasury, at cost: 36 million shares and 32 million shares at March 31, 2026 and June 30, 2025, respectively**: negative 7,218,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 161,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.